In January 2020, a biological anomaly was unleashed on the people of China. By March this event had infected the world in a global virus pandemic. While the US Government made forceful steps to limit further community spread their tactics had a profound and potentially long-term effect on the economy. In essence, most companies were transformed from flourishing to distress within a 45-day period. Our organization has deep experience managing through challenging times, particularly in the aesthetics industry, primarily in the med spas, cosmetic dermatology and plastic surgery practice arenas. In Q1 2020, we decided to expand our medical aesthetics acquisition activity with the formation of an institutionally-backed investment fund.

​

Our Management team intends to acquire well-managed aesthetics practices and will add investor value by:

• Enhancing core operating efficiencies and economies of scale

• Realizing synergies, cross-sell and strategic growth objectives

• Emphasizing plastic surgery, dermatology, medspa practice specialties

• Collaborating, evolving, innovating and creating true strategic advantage